Sign In
31 Jul 2024 16:00
The following amendment has been made to the Director/PDMR Shareholding announcement released on 8 July 2024 at 14:16 under RNS Number 5478V.
The correction relates to the volume of Ordinary Shares traded in the Company, the net impact of which should have been an increase in Lombard Odier Asset Management (Europe) Limited's holding in the Company of 14,705,882 Ordinary Shares. Amendments are identified with an asterisk.
All other details remain unchanged.
The full amended text is shown below.
Science in Sport plc
("Science in Sport" or the "Company")
Director/PDMR Shareholding
Science in Sport plc (AIM: SIS), the premium performance nutrition company serving elite athletes, sports enthusiasts and the gym lifestyle community, announces that it has been notified of the following transaction by a PDMR.
The information below set out in accordance with the requirement of the EU Market Abuse Regulation provides further detail.
Notification of a Transaction pursuant to Article 19(1) of Regulation (EU) No. 596/2014 | ||||||||
1 | Details of the person discharging managerial responsibilities/person closely associated | |||||||
a. | Name | Lombard Odier Asset Management (Europe) Limited | ||||||
2 | Reason for notification |
| ||||||
a. | Position/Status | PCA (on behalf of funds or discretionary mandates managed by Lombard Odier Asset Management (Europe) Limited) of Henry Turcan, Non-Executive Director | ||||||
b. | Initial notification/ Amendment | Initial Notification | ||||||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||||
a. | Name | Science in Sport plc | ||||||
b. | LEI | 213800FWYWBJFJPPJ981 | ||||||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||||
a. | Description of the financial instrument, type of instrumentIdentification Code | Ordinary Shares of 10 pence each ("Ordinary Shares") ISIN: GB00BBPV5329 | ||||||
b. | Nature of the transaction | 1) Purchase of Ordinary Shares* 2) Purchase of Ordinary Shares* 3) Sale of Ordinary Shares*
| ||||||
c. | Price(s) and volume(s) | |||||||
Price(s) | Volume(s) | |||||||
1) 17 pence* 2) 17 pence* 3) 17 pence* | 1) 13,093,882* 2) 6,055,849* 3) 4,443,849*
| |||||||
d. | Aggregated information - Aggregated Volume - Price | Purchased: 19,149,731 at 17 pence* Sold: 4,443,849 at 17 pence* | ||||||
e. | Date of the transaction | 1) 24 July 2024* 2) 5 July 2024* 3) 5 July 2024*
| ||||||
f. | Place of the transaction | London Stock Exchange, AIM | ||||||
For further information:
Science in Sport plc | T: +44 (0) 20 7400 3700 |
Daniel Wright, Executive Chairman Daniel Lampard, Chief Operating Officer Christopher Welsh, Chief Financial Officer
| |
Panmure Liberum Limited (Nominated Adviser and Broker) | T: +44 (0) 20 3100 2000 |
Richard Lindley John More Anake Singh
|
About Science in Sport plc
Headquartered in London, Science in Sport plc is a leading sports nutrition business that develops, manufactures, and markets innovative nutrition products for professional athletes, sports and fitness enthusiasts and the active lifestyle community. The Company has two highly regarded brands, PhD Nutrition, a premium active-nutrition brand targeting the active lifestyle community, and SiS, a leading endurance nutrition brand among elite athletes and professional sports teams.
The two brands sell through the Company's phd.com and scienceinsport.com digital platforms, third-party online sites, including Amazon and eBay, and extensive retail distribution in the UK and internationally, including major supermarkets, high street chains and specialist sports retailers. This omnichannel footprint enables the Company to address the full breadth of the sports nutrition market.
PhD is one of the UK's leading active nutrition brands with a reputation for high quality and product innovation. The brand has grown rapidly since its launch in 2005. The range now comprises powders, bars, and supplements, including the high protein, low sugar range, PhD Smart.
SiS, a leading endurance nutrition business founded in 1992, has a core range comprising gels, powders and bars focused on energy, hydration, and recovery. SiS is an official endurance nutrition supplier to over 320 professional teams, organisations, and national teams worldwide. SiS supplies more than 150 professional football clubs in the UK, Europe, and the USA.
SiS is Performance Solutions partner to Ineos Grenadiers cycling team, and Tottenham Hotspur and CGC Nice football clubs.
For further information, please visit phd.com and scienceinsport.com
Follow the stocks
